Johnson & Johnson stock heads into the open after a 0.3% Nasdaq dip

At the close on September 10, 2026, Johnson & Johnson stock finished at USD 266.35 on the Nasdaq, down 0.3 percent, with a day range between USD 265.72 and USD 271.27. The move left the shares roughly 5 percent below their 52-week high as investors digested fresh analyst commentary.

Johnson & Johnson stock closed at USD 266.35 on the Nasdaq on September 10, 2026, down 0.3 percent from the prior session based on exchange data. The shares traded between USD 265.72 and USD 271.27 during the session, with volume at about 4.84 million shares, moderately below the recent 65 day average per Nasdaq data summarized by MarketWatch. The closing level left the stock roughly 5 percent below its 52-week high of USD 281.07, while still well above the 52-week low near USD 173.33.

September 10, 2026 in numbers

Johnson & Johnson Inc. (ISIN US4781601046, NYSE: JNJ) saw a relatively narrow trading range on September 10, 2026, with the Nasdaq quote showing an intraday high of USD 271.27 and a low of USD 265.72, before settling at USD 266.35 at the close according to MarketWatch data. The session’s volume of around 4.84 million shares compared with a 65 day average of roughly 7.77 million, indicating lighter trading activity than usual. MarketWatch data also placed the 52-week span for the shares between USD 173.33 and USD 281.07, underscoring that the latest close remains closer to the upper end of the yearly range. While the broader United States equity benchmarks were mixed, Johnson & Johnson’s modest decline contrasted with analyst commentary highlighting valuation concerns, as GuruFocus noted the shares trading more than 30 percent above its proprietary fair value estimate.

Outlook for today, September 11, 2026

Looking ahead to today, Johnson & Johnson carries a recently confirmed quarterly dividend of USD 1.34 per share, with the last ex-dividend date on August 25, 2026 and the corresponding payout scheduled for September 8, 2026, according to the dividend history compiled by StockAnalysis. The company’s next major scheduled event is its third quarter 2026 earnings call on October 13, 2026, as indicated on the investor relations calendar of Johnson & Johnson, so today’s trading is likely to be guided mainly by broader sector sentiment and ongoing discussion of valuation following this week’s analyst assessments, including a maintained buy rating and raised price target to USD 320 reported by Benzinga.